TTD Drug ID: DCL000940

Drug Information
Name	PYY3-36
Company	Nastech/Merck
Indication	Obesity [ICD9: 278   ICD10: E66]			Discontinued in Phase II    [1]
ClinicalTrials.gov	NCT00468884;
Target	Neuropeptide Y receptor type 2			Agonist	[2]
Ref 1	Emerging drugs for acute and chronic heart failure: current and future developments. Expert Opin Emerg Drugs. 2007 Mar;12(1):75-95. To Reference
Ref 2	Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.